SCHEDULES

SCHEDULE 2 U.K. Amendment of the Human Medicines (Amendment etc.) (EU Exit) Regulations 2019

PART 9 U.K. Amendment of Part 10 (amendment of Part 10 (exceptions to requirement for marketing authorisations etc))

106.  In regulation 138 (amendment of regulation 173 (exemption for certain radiopharmaceuticals)), for “insert “ UK ” before “marketing authorisation” ” substitute “for “marketing authorisation” substitute “ UK marketing authorisation or EU marketing authorisation ””. U.K.

Commencement Information

I1 Sch. 2 para. 106 in force at 31.12.2020 immediately before IP completion day, see reg. 1